IL-12 Gene Therapy Using an Electrically Mediated Nonviral Approach Reduces Metastatic Growth of Melanoma

DNA and Cell Biology

Volumn 22, Issue 12, 2003, Pages 755-763

  Lucas, M Lee ^a   Heller, Richard ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; GENE THERAPY; IMMUNOTHERAPY; LUNG METASTASIS; MELANOMA; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; TREATMENT PLANNING;

ANGIOGENESIS INHIBITORS; ANIMALS; ELECTROPORATION; GENE THERAPY; INTERLEUKIN-12; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PLASMIDS; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0346732375     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454903322624966     Document Type: Article

References (46)

1. AIHARA, H., and MIYAZAKI, J. (1998). Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867-870.
2. BAJETTA, E., VECCHIO, M., MORTARINI, R., NADEAU, R., RAKHIT, A., RIMASSA, L., FOWST, C., BORRI, A., ANICHINI, A., and PARMIANI, G. (1998). Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma. Clin. Cancer Res. 4, 75-85.
3. BRUNDA, M.J., LUISTRO, L., HENDRZAK, I.A., FOUNTOULAKIS, M., GAROTTA, G., and GATELY, M.K. (1995). Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12. J. Immunother. 17, 71-77.
4. BRUNDA, M., LUISTRO, L., WARRIER, R., WRIGHT, R., HUBBARD, B., MURPHY, M., WOLF, S., and GATELY, M. (1993). Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178, 1223-1230.
5. CHAN, S.H., PERUSSIA, B., GUPTA, I.W., KOBAYASHI, M., POSPISIL, M., YOUNG, H.A., WOLF, S.F., YOUNG, D., CLARK, S.C., and TRINCHIERI, G. (1991). Induction of interferon production by natural killer cell stimulatory factor: characterization of the responding cells and synergy with other inducers. I. Exp. Med. 148, 869-879.
6. EGILMEZ, N.K., JONG, Y.S., SABEL, M.S., JACOB, J.S., MATHIOWITZ, E., and BANKERT, R.B. (2000). In situ tumor vaccination with interleukin-12- encapsulated biodegradable microshperes: Induction of tumor regression and potent antitumor immunity. Cancer Res. 60, 3832-3837.
7. GAMBOTTO, A., TUTING, T., McVEY, D.L., KOVESDI, I., TAHARA, H., LOTZE, M.T., and ROBBINS, P.D. (1999). Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expression interleukin-12. Cancer Gene Ther. 6, 45-53.
8. GEE, M.S., KOCH, C.J., EVANS, S.M., JENKINS, W.T., PLETCHER, C.H., JR., MOORE, J.S., KOBLISH, H.K., LEE, J., LORD, E.M., TRINCHIERI, G., et al. (1999). Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12. Cancer Res. 59, 4882-4889.
9. GLASSPOOL-MALONE, J., SOMIARI, S., DRABICK, J., and MALONE, R. (2000). Efficient nonviral cutaneous transfection. Mol. Ther. 2, 140-146.
10. GOTO, T., NISHI, T., TAMURA, T., DEV, S., TAKESHIMA, H., KOCHI, M., YOSHIZATO, K., KURATSU, J., SAKATA, T., HOFMANN, G., et al. (2000). Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA. 97, 354-359.
11. HELLER, L., and LUCAS, M. (2000). Delivery of plasmid DNA by in vivo electroporation. Gene Ther. Mol. Biol. 5, 50-55.
12. HELLER, L., JAROSZESKI, M.J., COPPOLA, D., POTTINGER, C., GILBERT, R., and HELLER, R. (2000a). Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo. Gene Ther. 7, 826-829.
13. HELLER, L.C., INGRAM, S.F., LUCAS, M.L., GILBERT, R.A., and HELLER, R. (2002). Effect of electrically mediated intratumor and intramuscular delivery of a plasmid encoding IFN α on visible B16 mouse melanomas. Technol. Cancer Res. Treat. 1, 205-209.
14. HELLER, R., JAROSZESKI, M., ATKIN, A., MORADPOUR, D., GILBERT, R., WANDS, J., and NICOLAU, C. (1996). In vivo gene electroinjection and expression in rat liver. FEBS Lett. 389, 225-228.
15. HELLER, R., JAROSZESKI, M.J., REINTGEN, D., PULEO, C., DECONTI, R., GILBERT, R., and GLASS, L.F. (1998). Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 83(1), 148-157.
16. HELLER, L.C., POTTINGER, C., JAROSZESKI, M.J., GILBERT, R., and HELLER, R. (2000b). In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumor immunity. Melanoma Res. 10, 577-583.
17. HOOVER, F., and KALHOVDE, J. (2000). A double-injection DNA electroporation protocol to enhance in vivo gene delivery in skeletal muscle. Anal. Biochem. 285, 175-178.
18. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDON, R., SHERMAN, F., PERUSSIA, B., and TRINCHIERI, G. (1989). Identification and purification of natural killer stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
19. KODAMA, R., TAKEDA, K., SHIMOZATO, O., HAYAKAWA, Y., ATSUTA, M., KOBAYASHI, K., ITO, M., YAGITA, H., and OKUMURA, K. (1999). Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12. Eur. J. Immunol. 29, 1390.
20. LAWSON, B.R., PRUD'HOMME, G.J., CHANG, Y., GARDNER, H.A., KUAN, J., KONO, D.H., and THEOFILOPOULOS, A.N. (2000). Treatment of murine lupus with cDNA encoding IFN-γR/FC. J. Clin. Invest. 106, 207-215.
21. LI, S., ZHANG, X., and XIA, X. (2002). Regression of tumor growth and induction of long-term anti-tumor memory by interleukin-12 electro-gene therapy. J. Natl. Cancer Inst. 94, 762-768.
22. LOHR, F., LO, D., ZAHAROFF, D., HU, K., ZHANG, X., YONGPING, L., ZHAO, Y., DEWHIRST, M., YUAN, F., and LI, C. (2001). Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation. Cancer Res. 61, 3281-3284.
23. LUCAS, M., and HELLER, R. (2001). Immumodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol. Ther. 3, 47-53.
24. LUCAS, M.L., HELLER, L., COPPOLA, D., and HELLER, R. (2002). IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol. Ther. 5, 668-675.
25. MARSHALL, E. (1995). Cancer trial of interleukin-12 halted. Science 268, 1555.
26. MATHIESON, I. (1999). Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther. 6, 508-514.
27. MIR, L.M., BUREAU, M.F., GEHL, J., RANGARA, R., ROUY, D., CAILLAUD, J-M., DELAERE, P., BRANELLEC, D., SCHWARTZ, B., and SCHERMAN, D. (1999). High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. USA 96, 4262-4267.
28. MURAMATSU, T., SHIBATA, O., RYOKI, S., et al. (1997). Foreign gene expression in the mouse testis by localized in vivo gene transfer. Biochem. Biophys. Res. Commun. 233, 45-49.
29. NISHI, T., YOSHIZATO, K., YAMASHIRO, S., TAKESHIMA, H., SATO, K., HAMADA, K., KITAMURA, I., YOSHIMURA, T., SAYA, H., KURATSU, J., et al. (1996). High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res. 56, 1050-1055.
30. NIU, G., HELLER, R., CATLETT-FALCONE, R., COPPOLA, D., JAROSZESKI, M., DALTON, W., JOVE, R., and YU, H. (1999). Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res. 59, 5059-5063.
31. RAKMILEVICH, A., TIMMINS, J., JANSSEN, K., POHLMANN, E., SHEEHY, M., and YANG, N. (1999). Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: A direct comparison with systemic IL-12 protein therapy. J. Immunother. 22, 135-144.
32. ROLS, M., DELTEIL, C., GOLZIO, M., DUMOND, P., CROS, S., and TEISSIE, J. (1998). In vivo electrically mediated protein and gene transfer in murine melanoma. Nat. Biotechnol. 16, 168-171.
33. SCHULTZ, J., PAVLOVIC, J., STRACK, B., NAWRATH, M., and MOELLING, K. (1999). Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA. Hum. Gene Ther. 10, 407-417.
34. SGADARI, C., ANGIOLILLO, A., and TOSATO, G. (1996). Inhibition of angiogenesis by interleukin-12 is mediated by the interferoninducible protein-10. Blood 87, 3877-3882.
35. SHURIN, M.R., Esche, C., PERON, J., and LOTZE, M. (1997). Anti-tumor activities of IL-12 and mechanisms of action. Chem. Immunol. 68, 153-174.
36. STERN, A., MAGRAM, J., and PRESKY, D. (1996). Interleukin-12 an integral cytokine in the immune response. Life Sci. 58, 639-654.
37. STERN, A.S., PODLASKI, F.J., HULMES, J.D., PAN, Y.C., QUINN, P.M., WOLITZKY, A.G., FAMILLETTI, P.C., STREMLO, D.L., TRUITT, T., CHIZZONITE, R., et al. (1990). Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87, 6808-6812.
38. TITOMIROV, A., SUKHAREV, S., and KISTANOVA, E. (1991). In vivo electroporation and stable transformation of skin cells of new-born mice by plasmid DNA. Biochim. Biophys. Acta. 1088, 131-134.
39. TODA, M., MARTUZA, R., KOJIMA, H., and RABKIN, S. (1998). In situ cancer vaccination: An IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity. J. Immunol. 160, 4457-4464.
40. VICAT, J.M., BOISSEAU, S., JOURDES, P., LAINE, M., WION, D., BOUALI-BENAZZOUZ, R., BENABID, A., and BERGER, F. (2000). Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression. Hum. Gene Ther. 11, 909-916.
41. VOEST, E.E., KENYON, B.M., O'REILLY, M.S., TRUITT, G., D'AMATO, R.J., and FOLKMAN, J. (1995). Inhibition of angiogenesis in vivo by interleukin 12. J. Nat. Cancer Inst. 87, 581-586.
42. WELLS, J., LI, L., SEN, A., JAHREIS, G., and HUI, S. (2000). Electroporation-enhanced gene delivery in mammary tumors. Gene Ther. 7, 541-547.
43. WIDERA, G., AUSTIN, M., RABUSSAY, D., GOLDBECK, C., BARNETT, S. CHEN, M., LEUNG, L., OTTEN, G., THUDIUM, K., SELBY, M., et al. (2000). Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J. Immunol. 164, 4635-4640.
44. YAMASHITA, Y., SHIMADA, M., HASEGAWA, H., MINAGAWA, R., RIKIMARU, T., HAMATSU, T., TANAKA, S., SHIRABE, K., MIYAZAKI, I., and SUGIMACHI, K. (2001). Electroporation-mediated interkeukin-12 gene therapy for heptocellular carcinoma in the mice model. Cancer Res. 61, 1005-1012.
45. YU, W.G., OGAWA, M., MU, I., UMEHARA, K., TSUJIMURA, T., FUJIWARA, H., and HAMAOKA, T. (1997). IL-12-induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways. J. Leukoc. Biol. 62, 450-457.
46. YUE, F., GEERTSEN, R., HEMMI, S., BURG, G., PAVLOVIC, J., LAINE, E., and DUMMER, R. (1999). IL-12 directly up-regulates the expression of HLA class I, HLA class II, and ICAM-1 on human melanoma cells: A mechanism for its antitumor activity? Eur. J. Immunol. 29, 1762-1773.